Fig. 2From: RSV prophylaxis use in high-risk infants in Western Australia, 2002-2013: a record linkage cohort studyProportion of infants receiving at least one dose of palivizumab by a eligibility criteria and b those not meeting the eligibility criteria. Note the differences in scale between a and bBack to article page